![Charles York](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles York
Director Ejecutivo en
MERSANA THERAPEUTICS
.
Perfil
Charles N.
York is currently President, CEO, COO, CFO, and Director at Mersana Therapeutics, Inc. since 2026.
He is also Chief Operating & Financial Officer at DOT Therapeutics-2, Inc. and Day One Biopharmaceuticals, Inc., both positions held since 2021.
Formerly, Mr. York was Controller at Astrotech Corp.
from 2009 to 2012.
From 2015 to 2021, served as Chief Financial Officer, Secretary, and VP at Spyre Therapeutics, Inc. Education includes an undergraduate degree from the University of Connecticut in 1999 and an MBA from McCombs School of Business in 2006.
Cargos activos de Charles York
| Empresas | Cargo | Inicio |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Director Financiero/CFO | 01/02/2021 |
| MERSANA THERAPEUTICS | Director Ejecutivo | 06/01/2026 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Director Financiero/CFO | 17/02/2021 |
Antiguos cargos conocidos de Charles York.
| Empresas | Cargo | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director Financiero/CFO | 12/02/2021 |
| ASTROTECH CORPORATION | Comptroller/Controller/Auditor | 01/08/2012 |
Formación de Charles York.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
68
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Astrotech Corp.
 Astrotech Corp. Aerospace & DefenseElectronic Technology Develops, manufactures and sells trace detectors | Electronic Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McCombs School of Business
 McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
- Bolsa de valores
- Insiders
- Charles York
Elige MarketScreener 
